In 2025, Ajanta Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Ajanta Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ajanta Pharma’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions of Ajanta Pharma amounted to 49,990.47 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Ajanta Pharma increased by 7.74%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2025, the total Scope 1 emissions of Ajanta Pharma were 6,392 metric tons of CO₂ equivalent (tCO₂e). a
Since 2022, Ajanta Pharma's Scope 1 emissions have increased by 38.62%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2024), Ajanta Pharma's Scope 1 emissions remained relatively stable, indicating that Ajanta Pharma's emissions have plateaued with no significant change in its operational footprint. a
In 2025, Ajanta Pharma reported Scope 2 greenhouse gas (GHG) emissions of 43,598.47 tCO₂e without specifying the calculation method. a
Since 2022, Ajanta Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Ajanta Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2024), Ajanta Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Ajanta Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2025, Ajanta Pharma reported its Scope 2 emissions using an unspecified methodology. a
In 2025, Ajanta Pharma reported 10,790 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2025 disclosure of Ajanta Pharma includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
In 2025, Ajanta Pharma reported total Scope 3 emissions of 10,790 metric tons of CO₂ equivalent (tCO₂e). a
In 2025, Ajanta Pharma reported Scope 1 greenhouse gas (GHG) emissions of 6,392 tCO₂e and total revenues of USD 537 millions. This translates into an emissions intensity of 11.9 tCO₂e per millions USD. a
In 2025, Ajanta Pharma reported a Scope 1 emissions intensity of 11.9 tCO₂e per millions USD. Compared to the peer group median of 28.64 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2025, Ajanta Pharma ranked 4 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Ajanta Pharma among the top performers, with one of the lowest emissions intensities relative to peers. a
In 2025, Ajanta Pharma reported a total carbon footprint of 60,780.47 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 31% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Ajanta Pharma's total carbon footprint was Scope 2 emissions, accounting for 71.73% of the company's total carbon footprint, followed by Scope 3 emissions at 17.75%. a